Melanoma laboratory tests
From Wikidoc - Reading time: 2 min
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Serge Korjian M.D.
|
Melanoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
2019 AAD Guidelines for management of Primary Cutaneous Melanoma (CM) |
|
Case Studies |
|
Melanoma laboratory tests On the Web |
|
American Roentgen Ray Society Images of Melanoma laboratory tests |
|
Risk calculators and risk factors for Melanoma laboratory tests |
Overview[edit | edit source]
There are no laboratory findings associated with the diagnosis of melanoma. Serum lactate dehydrogenase (LDH) may be elevated among patients with metastasis.
Laboratory Findings[edit | edit source]
- There are no laboratory findings associated with the diagnosis of melanoma. Measurement of serum LDH may be considered for follow-up among patients who have been diagnosed with stage IB-IV melanoma.[1]
Lactate Dehydrogenase (LDH)[edit | edit source]
- Once metastatic melanoma is diagnosed, serum lactate dehydrogenase (LDH) may be helpful for follow-up.[1]
- For patients with stage IB-IV melanoma, measurement of serum LDH may be considered every 6-12 months.[1]
References[edit | edit source]
Licensed under CC BY-SA 3.0 | Source: https://www.wikidoc.org/index.php/Melanoma_laboratory_tests14 views | Status: cached on September 27 2025 22:35:16↧ Download this article as ZWI file
EncycloReader
is supported by the 
KSF